Advancing best practices in cryogenic cold chain solutions.
Advancing best practices in cryogenic cold chain solutions

Sharing fundamental research, education, discussion and best practices for cryogenic cold chain management, biobanking, glass transition; biosample storage, preparation, planning and recovery and associated issues.


John Fink

John Fink is marketing manager for cryogenic solutions at Brooks Life Science Systems, the global leader in automated cold-chain sample management for drug discovery and biostorage applications and a division of Brooks Automation, Inc. if you have any questions or ideas for future blog posts.

Prior Planning & Next-Gen Biological Repositories

April 17, 2015

Who remembers the old saying: “Prior Planning Prevents Poor Performance?” Though well-worn, the truism may have relevance when it comes to — of all things — next-generation biological repositories.

As Ian Pope notes, an NIH estimate of up to 70% of all of the sample material stored at -80°C and below is unusable because of its lack of provenance.

The preferred alternative “effective planning” Pope says will provide two benefits: sample value and viability — and cost reduction. To that end, he gives us five key steps to use in developing an archival sample storage strategy: Storage Objective, Biological Viability, Thermal Performance, Environmental Impact, and Cost. A good read for those in the biobanking, biorepository space.

Download the white paper to learn more »